MOTS-C (Mitochondrial open reading frame of the 12S rRNA-c) is a peptide encoded in mitochondrial DNA. It improves glucose metabolism in skeletal muscle, which implies a number of benefits for those with diabetes, obesity, or who are over 30 years old. It is upregulated in response to exercise, and is considered an exercise mimetic.
An exercise mimetic is a drug or compound that mimics the beneficial physiological effects of physical exercise on the body, essentially providing some of the health benefits of working out without the need for actual physical activity. It aims to activate similar cellular pathways triggered by obesity, diabetes, or muscle-wasting by simulating exercise-induced adaptations in the body. This provides a viable alternative to physical exercise in populations who are unable to exercise due to any number of limitations. Also, naturally occurring levels of MOTS-C diminish substantially throughout the aging process.
Dysregulated MOTS-C levels have been associated with defective insulin secretion, insulin resistance, or both. This results in dysregulated mitochondrial activities such as mitochondrial fission and fusion, mitochondrial oxidative stress, and decreased NAD+ levels in the system. MOTS-C interacts with and regulates many nuclear genome-encoded proteins responsible for regulating metabolic adaptability and age-related diseases.
Benefits
- Weight loss
- Increased metabolism
- Can help protect against metabolic disorders, e.g. nonalcoholic steatohepatitis (NASH)
- Reduces visceral fat, including liver fat
- Increases life expectancy
- Useful in the treatment of cardiovascular disease, inflammation, and aging
- Can improve physical performance and running capacity
- Improves muscle function
- Reduces insulin resistance
- Prevents macular eye degeneration
- Corrects diabetes-induced abnormal cardiac structures and functions
- Offers significant reduction in vascular calcification
- Has immunoregulatory benefits
- Mitigates chemotherapy-induced side effects
- Delays Alzheimer’s
- Anti-inflammatory benefits for those with multiple chronic age-related diseases
- Inhibits inflammatory pain
- Fights bacterial infections, especially MRSA
- Increases chance of surviving infection and/or sepsis
Synergistic Peptides
- Frag 176-292
- Humanin
- Tesofensine
- SS-31 – MOTS-C is best cycled after a cycle of SS-31. SS-31 essentially preps the mitochondria for the mechanism of action that MOTS-C then exerts on them. Synergistic peptides are combinations of two peptides whose cumulative benefits surpass what either is able to accomplish when cycled independently.
Possible Side Effects
- Injection site reaction (redness, swelling, itching)
- Headache
- Mild gastrointestinal disturbances
- Rare: Oxidative stress or tissue fatigue may occur with overuse
Stacking Suggestions
- SS-31 – always use prior to MOTS-C for mitochondrial priming
- Humanin – for powerful anti-aging, cell-protective synergy with MOTS-C
- Tesofensine – enhances fat-burning and metabolic benefits
- AOD-9604 or CJC-1295 – for added weight loss or GH pathway stimulation
- BPC-157 or TB-500 – to support performance, muscle preservation, and inflammation reduction
- Glutathione or NAD+ precursors – for longevity and mitochondrial support during MOTS-C use
